Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
118.83
Nov 06 • 3:59 PM ET Dollar change-0.20 Percentage change(-0.17%)
Aftermarket Close
118.83
Aftermarket • 7:30 PM ET Dollar change0.00 Percentage change(0.00%)
Category
Global or ExUS Equities - Industry Sector
Sponsor
Van Eck Associates Corporation
Fund Family
Index
MVIS US Listed Pharmaceutical 25 Index
Index Weighting
Active/Passive
Expense
0.36%
Inverse/Leveraged
IPO
Dec 21, 2011
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
Tags
-
Tags
-
Tags
-
Sector/Theme
Region
SMA20
2.63%
SMA50
5.23%
SMA200
9.76%
Return% 1Y
29.43%
Return% 3Y
18.70%
Return% 5Y
11.74%
Return% 10Y
Return% SI
Flows% 1M
-3.70%
Flows% 3M
3.77%
Flows% YTD
-23.96%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
26
AUM
1.07B
NAV/sh
52W High
123.53 -3.80%
52W Low
93.11 27.62%
Volatility
2.27% 1.71%
ATR (14)
2.41
RSI (14)
59.89
Beta
0.42
Rel Volume
0.93
Avg Volume
315.91K
Volume
292,355
Perf Week
-0.42%
Perf Month
8.84%
Perf Quarter
5.40%
Perf Half Y
19.02%
Perf YTD
15.18%
Perf Year
26.01%
Perf 3Y
54.20%
Perf 5Y
55.94%
Perf 10Y
132.18%
Prev Close
119.03
Price
118.83
Change %
-0.17%
VanEck Pharmaceutical ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.